Stock OBD OXFORD BIODYNAMICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Oxford BioDynamics Plc

Equities

OBD

GB00BD5H8572

Delayed London S.E.
Other stock markets
 06:58:10 10/05/2024 pm IST 		5-day change 1st Jan Change
7.931 GBX +1.68% Intraday chart for Oxford BioDynamics Plc -0.86% -71.68%
03/04 Oxford BioDynamics reaches "important milestone" with new laboratory AN
03/04 Oxford BioDynamics Plc Opens Clinical Testing Facility in the UK to Perform EpiSwitch Prostate Screening Blood Test CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oxford BioDynamics reaches "important milestone" with new laboratory
Oxford BioDynamics Plc Opens Clinical Testing Facility in the UK to Perform EpiSwitch Prostate Screening Blood Test
Oxford Biodynamics Raises GBP9.9 Million to Support EpiSwitch Product Line
FireAngel CFO resigns; ECR Minerals raises GBP585,000
EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal
Oxford BioDynamics plunges as annual loss widens; revenue up
Oxford BioDynamics plunge as annual profit rises; revenue up
Oxford BioDynamics shares plunge as annual revenue widens; revenue up
AIM WINNERS & LOSERS: James Cropper falls on lower outlook
Earnings Flash (OBD.L) OXFORD BIODYNAMICS Reports FY23 Revenue GBP510,000
Oxford BioDynamics Plc Reports Earnings Results for the Full Year Ended September 30, 2023
Oxford BioDynamics Appoints Steven Arrivo as Senior Vice President of Business and Corporate Development
Oxford BioDynamics director sells over 700,000 shares
Oxford BioDynamics Strikes Deal with Bupa for Access to Blood Test
Oxford BioDynamics in deal with Bupa to expand blood test access
Oxford BioDynamics, Plc Announces a Strategic Agreement to Give Bupa Patients Access to OBD'sEpiSwitch CiRT
AIM WINNERS & LOSERS: Safestyle plunges as seeks cash injection
Oxford BioDynamics issued insurance reimbursement code for EpiSwitch
Oxford BioDynamics soars as validates prostate test ahead of schedule
Oxford Biodynamics Surges 92% With Early Launch of Prostate Screening Test
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OBD Stock
  4. News Oxford BioDynamics Plc
  5. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW